Serial retrospective and double-blinded studies were conducted in 2012–2020 [58,59,60,61] in patients with Dravet syndrome associated with SCN1A with results showing excellent efficacy and tolerance. The gene discussed is SCN1A; the disease is Dravet syndrome.